HOME >> MEDICINE >> NEWS
'Vioxx like' drugs may still be best option for arthritis, write scientists

Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.

In a Nature Reviews of Drug Discovery article this month the researchers from Imperial College London and Queen Mary, University of London examine the use of selective inhibitors of cyclo-oxygenase-2 (COX-2).

They argue that although this class of drugs, which includes Vioxx, has been associated with an increase in the risk of cardiovascular events such as heart attacks and strokes in some patients, the same may be true for traditional non-steroid anti-inflammatory drugs (NSAIDs).

All NSAIDs, including COX-2 inhibitors, work by blocking the actions of both COX-1 and COX-2 enzymes. Blocking COX-2 relieves inflammation and pain, but blocking COX-1 can increase the risk of gastric ulcers and bleeds. For this reason COX-2 selective drugs were developed with the simple aim that they would retain the therapeutic actions of NSAIDs (linked to inhibition of COX-2) but lose the gastric side effects (linked to inhibition of COX-1).

The researchers reviewed over one hundred papers on the subject and looked at the latest recommendations from organisations such as the American Federal Drugs Administration on the use of COX-2 inhibitors and NSAIDs.

The researchers point out that the calls for the removal of COX-2 inhibitors, and a return to using NSAIDs, may cause additional problems. Although NSAIDs have been marketed for a number of years, they have never been required to meet the clinical trial standards now set for COX-2 inhibitors, meaning they may not be any safer.

Professor Jane Mitchell, from Imperial College London, and one of the reviews authors, said: "Although some COX-2 drugs have been reported to increase the risk of heart attack and stroke, they may still remain the best option for treating arthritis in some patients without cardiovascular risk facto
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.ac.uk
44-207-594-6712
Imperial College London
18-Jan-2006


Page: 1 2

Related medicine news :

1. UIC researchers to develop new drugs to fight bioterrorism
2. Statin drugs may delay progressive artery damage in children
3. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
4. Experts call for urgent research into anti-epileptic drugs given to children
5. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
6. Antipsychotic drugs increase risk of death in older people with dementia
7. Antipsychotic drugs increase risk of death in older people with dementia
8. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
9. Panel offers guidelines on skin reactions to new class of cancer drugs
10. Blood-thinning drugs need closer monitoring
11. Comparison of patients access to new and better cancer drugs reveals inequalities between countries

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vioxx like drugs may still best option for arthritis write scientists

(Date:5/27/2015)... With the launch of the Centers for Medicare ... (NMM) tool, monitoring provider-network adequacy will take a technological ... Services, Inc.’s (AIS) Medicare Advantage News (MAN) offers in-depth ... analysis from industry experts on why CMS is moving ... NMM were announced at CMS’s recently held annual spring ...
(Date:5/27/2015)... 2015 The new http://www.carsonenergy.com ... investors should consider oil and gas investing, the substantial ... are drilled, industry news, IRA investing, definitions and acronyms, ... of knowledge and experience is now in one central ... be able to access 24 hours a day, 7 ...
(Date:5/27/2015)... 27, 2015 The Case Management ... partnership to provide CMSA's Career and Knowledge Pathways ... seeks to strengthen the case/care management workforce by ... program. The mutually beneficial agreement provides Medix, a ... of talent in the healthcare, scientific and IT ...
(Date:5/27/2015)... View, CA (PRWEB) May 27, 2015 Coco ... Valley will be able to reach for Organic Coconut Water ... Coco Libre will be available at VIP areas, artist greenrooms, ... also be available at area hotels and on festival shuttle ... a partner this year,” said Noa Elan, Director of Strategic ...
(Date:5/27/2015)... IL (PRWEB) May 27, 2015 ... of its SonarMD Platform, a first-of-its kind, ... and managing patients with chronic gastrointestinal disease. ... MD, MBA, the application allows physicians to ... through the ongoing use of electronic health ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2
(Date:5/27/2015)... REDWOOD CITY, Calif. , May 27, 2015  Genomic ... Brad Cole , Chief Operating Officer and Chief Financial Officer, ... New York City on Monday, June ... access the live and subsequently archived webcast of the presentation, ... site at http://investor.genomichealth.com .  Please connect to the web ...
(Date:5/27/2015)...  Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... that Ross Taylor , vice president of business ... chief financial officer effective August 1, 2015, will present ... June 4, 2015 at 10:00 a.m. ET. The conference ... New York City . About ...
(Date:5/27/2015)... DUBLIN, Ohio , May 27, 2015 /PRNewswire/ ... present a new series of health economic outcomes ... evaluating real-world treatment patterns when developing value-based reimbursement ... , vice president and chief medical officer of ... and pharmaceutical companies alike have known for more ...
Breaking Medicine Technology:Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 2New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 3
Cached News: